Skip to main content
1-800-833-0680NET 30 Available
14 Panel Magenta Dip Card Flood Proof (with Fentanyl + EtG Alcohol) test device showing result windows for Amphetamine, Barbiturates, Buprenorphine, Benzodiazepines and 10 more analytes
1 / 4

14 Panel Magenta Dip Card Flood Proof (with Fentanyl + EtG Alcohol)

★★★★★4.8(12 reviews)
In Stock

14-panel urine dip card screening for Amphetamine, Barbiturates, Buprenorphine, and 11 more. Manufacturer SKU MGDDOA-8145EF.

Volume Pricing

QuantityUnit Price
1–4 packs25–100 testsCurrent$2.68/test
5–20 packs125–500 tests$2.48/test
21–80 packs525–2,000 tests$2.35/test
81+ packs2,025+ tests$2.13/test

Quantity (packs)

= 25 tests
1 pack·$2.68/test$67.00

Add 4 more packs to unlock $2.48/test

  • Ships today if ordered by 3pm ET
  • 30-day satisfaction guarantee
  • Bulk pricing available — request a quote
FDA Clearance
CLIA Status
Non-waived
Panels
14
Result Time
Shelf Life
Pack Sizes
25

14 Panel Magenta Dip Card Flood Proof (with Fentanyl + EtG Alcohol) is a 14-panel urine dip card from Magenta (manufacturer SKU MGDDOA-8145EF). It screens for Amphetamine, Barbiturates, Buprenorphine, and 11 more in a single device, with each analyte and cutoff drawn directly from the manufacturer's panel specification.

The device tests for the following 14 analytes at the cutoffs printed on the package insert:

  • Amphetamine (AMP): 1000 ng/mL
  • Barbiturates (BAR): 300 ng/mL
  • Buprenorphine (BUP): 10 ng/mL
  • Benzodiazepines (BZO): 300 ng/mL
  • Cocaine (COC): 300 ng/mL
  • Alcohol (EtG): 500 ng/mL
  • Fentanyl (FTY): 20 ng/mL
  • Methamphetamine (mAMP): 1000 ng/mL
  • Ecstasy (MDMA): 500 ng/mL
  • Morphine / Opiates (MOP): 300 ng/mL
  • Methadone (MTD): 300 ng/mL
  • Oxycodone (OXY): 100 ng/mL
  • Phencyclidine (PCP): 25 ng/mL
  • Marijuana (THC): 50 ng/mL

On this dip card, the individual test strips are housed in a durable plastic cartridge that holds them at a fixed position during collection. The collector dips the cartridge to the indicated MAX line, lays the device flat, and reads the result window once it has fully developed.

This device is sold for forensic, criminal-justice, harm-reduction, and behavioral-health screening programs where presumptive results inform a confirmation workflow. Confirm the device's indicated use with the package insert before deploying in a regulated clinical setting.

Typical buyers are behavioral-health clinicians, substance-use treatment programs, criminal justice supervision programs, and harm-reduction organizations that need single-analyte or low-panel screens against an already-collected urine sample.

Note from the owner's catalog: Per the owner's note: includes fentanyl and EtG alcohol.

Dip cards are typically chosen by programs that already have a separate collection container — for example, a behavioral-health clinician using a standard specimen cup at intake and then running a low-panel screen against the same sample. When comparing dip cards across vendors, look at the cartridge construction (a sturdy cartridge that holds the strips at a fixed immersion depth reduces wicking errors), the analyte-to-cutoff combinations available, and whether your bulk-purchase tier qualifies for case-pack pricing versus unit pricing.

Manufacturer SKU: MGDDOA-8145EF. Always read the lot number, expiration date, and proper read window from the package insert that ships with the device.

About the 14 Panel Magenta Dip Card Flood Proof (with Fentanyl + EtG Alcohol)

14 Panel Magenta Dip Card Flood Proof (with Fentanyl + EtG Alcohol) is a 14-panel urine dip card from Magenta (manufacturer SKU MGDDOA-8145EF). It screens for Amphetamine, Barbiturates, Buprenorphine, and 11 more in a single device, with each analyte and cutoff drawn directly from the manufacturer's panel specification.

The device tests for the following 14 analytes at the cutoffs printed on the package insert:

  • Amphetamine (AMP): 1000 ng/mL
  • Barbiturates (BAR): 300 ng/mL
  • Buprenorphine (BUP): 10 ng/mL
  • Benzodiazepines (BZO): 300 ng/mL
  • Cocaine (COC): 300 ng/mL
  • Alcohol (EtG): 500 ng/mL
  • Fentanyl (FTY): 20 ng/mL
  • Methamphetamine (mAMP): 1000 ng/mL
  • Ecstasy (MDMA): 500 ng/mL
  • Morphine / Opiates (MOP): 300 ng/mL
  • Methadone (MTD): 300 ng/mL
  • Oxycodone (OXY): 100 ng/mL
  • Phencyclidine (PCP): 25 ng/mL
  • Marijuana (THC): 50 ng/mL

On this dip card, the individual test strips are housed in a durable plastic cartridge that holds them at a fixed position during collection. The collector dips the cartridge to the indicated MAX line, lays the device flat, and reads the result window once it has fully developed.

This device is sold for forensic, criminal-justice, harm-reduction, and behavioral-health screening programs where presumptive results inform a confirmation workflow. Confirm the device's indicated use with the package insert before deploying in a regulated clinical setting.

Typical buyers are behavioral-health clinicians, substance-use treatment programs, criminal justice supervision programs, and harm-reduction organizations that need single-analyte or low-panel screens against an already-collected urine sample.

Note from the owner's catalog: Per the owner's note: includes fentanyl and EtG alcohol.

Dip cards are typically chosen by programs that already have a separate collection container — for example, a behavioral-health clinician using a standard specimen cup at intake and then running a low-panel screen against the same sample. When comparing dip cards across vendors, look at the cartridge construction (a sturdy cartridge that holds the strips at a fixed immersion depth reduces wicking errors), the analyte-to-cutoff combinations available, and whether your bulk-purchase tier qualifies for case-pack pricing versus unit pricing.

Manufacturer SKU: MGDDOA-8145EF. Always read the lot number, expiration date, and proper read window from the package insert that ships with the device.